Shanghai Yunhong shines at CPHI Frankfurt 2025
Release time：2025-12-12
168
On October 28, the top global pharmaceutical raw materials event—CPHI Worldwide 2025—was grandly inaugurated at the Frankfurt Exhibition Center in Germany. Shanghai Yunhong Chemical Preparations and Excipients Technology Co., Ltd., Shanghai Pulimembrane Preparations and Excipients Co., Ltd., and Pulimunhong (Shanghai) Pharmaceutical Technology Co., Ltd. jointly participated in the exhibition (booth number: 8.0 M94), becoming one of the most notable China enterprises at the event with their one-stop pharmaceutical excipients solutions and international service capabilities.
CPHI Worldwide, hailed as the "heart of the pharmaceutical industry," is held annually in major European cities and serves as a barometer platform for the global pharmaceutical supply chain. According to data from the official organizer, the Chemical Industry Branch of the China Council for the Promotion of International Trade, the CPHI Milan 2024 in Italy attracted over 1,800 exhibitors and more than 45,000 professional visitors worldwide due to the strong return of Chinese companies, including approximately 500 Chinese enterprises, accounting for 28% of the total exhibitors. It is expected that this year's Frankfurt exhibition will set a new record in scale, with exhibits covering the entire industry chain from active pharmaceutical ingredients, pharmaceutical excipients, formulations, biopharmaceuticals, to packaging materials.
At Booth 8.0 M94 in the Frankfurt Exhibition Center, Shanghai Yunhong's General Manager Bei Yan, Pulimembrane's General Manager Wang Mao, and Puliyunhong International Division Director He Ning were present with their core team to hold in-depth discussions with clients and partners from Europe and Asia. "At last year's Milan Exhibition, we deepened strategic partnerships with international suppliers like Germany's WACKER and CLARIANT. This year in Frankfurt, more clients have shown strong interest in our customized auxiliary material solutions," said Bei Yan, General Manager of Shanghai Yunhong.
Shanghai Yunhong's CPHI journey is a microcosm of its internationalization strategy. Since its establishment in 1998, the company has evolved from a pharmaceutical excipient supplier to a comprehensive service provider, collaborating with nearly 3,000 clients. At this exhibition, Shanghai Yunhong focused on promoting customized pharmaceutical excipient solutions, attracting attention from several European pharmaceutical companies. Bei Yan, General Manager of Shanghai Yunhong, pointed out: "China's pharmaceutical excipient enterprises are transitioning from 'supply chain participants' to 'technical partners.' For Xiaohong, with nearly 30 years of history and experience, this is both a challenge and an opportunity. Years of operation and development have enabled Xiaohong to provide one-stop solutions covering supply chain logistics, drug R&D services, regulatory consulting, and CDE registration, giving our clients peace of mind."
The current CPHI exhibition highlights three major trends: Green pharmaceuticals: surging demand for eco-friendly processes and sustainable packaging solutions, such as biodegradable capsules and low-carbon intermediates; Intelligent manufacturing: AI-driven quality control and continuous production technologies have become highlights in the equipment exhibition area; Supply chain diversification: under the backdrop of geopolitical tensions, European pharmaceutical companies are actively seeking alternative supplies of China raw materials and excipients. The number of Chinese exhibitors continues to grow, with a significant increase in the proportion of pharmaceutical excipients and formulation enterprises, reflecting the upgrading trend of China's pharmaceutical industry chain.
Under the night sky, the Frankfurt Exhibition Center remained brightly lit, with Xiaohong's team and clients still negotiating cooperation details at the booth. From Milan to Frankfurt, from a pharmaceutical excipient supplier to a one-stop service partner, Xiaohong's CPHI journey is a vivid footnote to the globalization process of China's pharmaceutical enterprises.
See you next year in Milan! 
Hotline：021-63534350/63534360
